Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
VIDEO
Allergan Shifts Strategy to Focus on Growth
By Scott Gamm
Jan 11, 2017 8:36 AM EST
STOCKS
Allergan to Veer Toward Accretive M&A
By Sarah Pringle
Jan 10, 2017 8:01 PM EST
STOCKS
Allergan continues down 'stepping stone' path with two deals
By Alicia McElhaney
Jan 9, 2017 11:13 AM EST
STOCKS
Allergan signs $2.9B deal
By Alicia McElhaney
Dec 20, 2016 10:06 AM EST
MERGERS AND ACQUISITIONS
Allergan's Vitae buy could spark more interest in Kadmon
By Sarah Pringle
Sep 23, 2016 6:25 AM EDT
FUTURES
Stocks hold higher as fed's yellen says economy picking up
By Keris Alison Lahiff
Sep 21, 2016 2:44 PM EDT
FUTURES
Stocks hold higher in wait for Fed, crude jumps on supply drop
By Keris Alison Lahiff
Sep 21, 2016 10:40 AM EDT
FUTURES
Stock futures rise as Bank of Japan tackles deflation
By Keris Alison Lahiff
Sep 21, 2016 9:04 AM EDT
MARKETS
Vitae Pharmaceuticals (VTAE) Stock Downgraded at BMO Capital
By Kaya Yurieff
Sep 15, 2016 10:00 AM EDT
MARKETS
Vitae Pharmaceuticals (VTAE) Stock Downgraded on $639 Million Allergan Deal
By Rachel Aldrich
Sep 14, 2016 3:23 PM EDT
MERGERS AND ACQUISITIONS
Allergan's dealmaking continues with vitae takeout
By Sarah Pringle
Sep 14, 2016 2:56 PM EDT
FUTURES
Stocks waver as oil tumbles but apple lifts nasdaq
By Keris Alison Lahiff
Sep 14, 2016 2:40 PM EDT
STOCKS
4 big stocks to add to your buy list -- plus 3 to avoid
By Jonas Elmerraji
Sep 14, 2016 2:09 PM EDT
FUTURES
Stocks add to gains as Apple boosts Dow, crude fluctuates
By Keris Alison Lahiff
Sep 14, 2016 10:50 AM EDT
MARKETS
Vitae Pharmaceuticals (VTAE) Stock Soars on $639 Million Allergan Deal
By Rachel Aldrich
Sep 14, 2016 10:37 AM EDT
FUTURES
Stock futures edge higher after a rocky three days
By Keris Alison Lahiff
Sep 14, 2016 8:44 AM EDT
MARKETS
Vitae Pharmaceuticals (VTAE) Is Weak On High Volume Today
By TheStreet Wire
Jun 17, 2016 10:30 AM EDT
OPINION
5 stocks under $10 set to soar
By Roberto Pedone
Apr 14, 2016 9:22 AM EDT
MARKETS
Vitae Pharma (VTAE) Stock Gets ‘Outperform’ Rating at BMO Capital
By Kaya Yurieff
Apr 12, 2016 9:06 AM EDT
MARKETS
Trade-Ideas: Vitae Pharmaceuticals (VTAE) Is Today's "Perilous Reversal" Stock
By TheStreet Wire
Mar 21, 2016 9:46 AM EDT
MARKETS
Vitae Pharmaceuticals (VTAE) Stock Continues to Gain on Positive Trial Results
By Kaya Yurieff
Mar 18, 2016 10:01 AM EDT
MARKETS
Vitae Pharmaceuticals (VTAE) Stock Skyrockets on Positive Trial Results
By Kaya Yurieff
Mar 17, 2016 12:22 PM EDT
MARKETS
Pre-Market Activity Shows Heavy Volume And Movement For Vitae Pharmaceuticals (VTAE)
By TheStreet Wire
Mar 17, 2016 8:15 AM EDT
OPINION
7 breakout stocks spiking on big volume
By Roberto Pedone
Mar 14, 2016 7:05 AM EDT
MARKETS
Vitae (VTAE) Stock Plunges on Q4 Loss
By Amanda Albright
Mar 4, 2016 9:59 AM EST
